BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33560380)

  • 21. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.
    Gibson SE; Liu YC; Yatsenko SA; Barasch NJ; Swerdlow SH
    Mod Pathol; 2022 Jan; 35(1):60-68. PubMed ID: 34601504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
    Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
    Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
    Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
    Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
    Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.
    Laurent C; Adélaïde J; Guille A; Tesson B; Gat E; Evrard S; Escudié F; Syrykh C; Canioni D; Fabiani B; Meignin V; Chassagne-Clement C; Dartigues P; Traverse-Glehen A; Parrens M; Huet S; Copie-Bergman C; Salles G; Birnbaum D; Brousset P; Morschhauser F; Xerri L;
    Am J Surg Pathol; 2021 Oct; 45(10):1324-1336. PubMed ID: 34334687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.
    Kim BK; Surti U; Pandya A; Cohen J; Rabkin MS; Swerdlow SH
    Am J Surg Pathol; 2005 Jan; 29(1):69-82. PubMed ID: 15613857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions.
    Massone C; Fink-Puches R; Cerroni L
    J Am Acad Dermatol; 2016 Nov; 75(5):1000-1006. PubMed ID: 27380773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
    Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
    Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
    Hristov AC; Tejasvi T; Wilcox RA
    Am J Hematol; 2023 Aug; 98(8):1326-1332. PubMed ID: 37434388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
    Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous follicle center lymphomas with plasmacytic differentiation.
    Skala SL; Harms PW; Fullen DR; Brown NA; Tejasvi T; Wilcox RA; Boyer DF; Hristov AC
    J Cutan Pathol; 2021 May; 48(5):632-636. PubMed ID: 33184902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
    Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
    Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profiling of primary cutaneous large B-cell lymphomas.
    Koens L; Qin Y; Leung WY; Corver WE; Jansen PM; Willemze R; Vermeer MH; Tensen CP
    PLoS One; 2013; 8(12):e82471. PubMed ID: 24358187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
    Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
    Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
    Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
    Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
    Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
    Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Cutaneous Follicle Center Lymphoma of the Eyelid: A Case Report and Review of the Literature in Light of Recent Changes to the WHO Classification of Lymphoid Neoplasms.
    Werner AC; Laver NV; Landmann DS
    Ocul Oncol Pathol; 2019 Feb; 5(2):147-152. PubMed ID: 30976595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
    Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
    Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.